JP2004537030A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004537030A5 JP2004537030A5 JP2002550119A JP2002550119A JP2004537030A5 JP 2004537030 A5 JP2004537030 A5 JP 2004537030A5 JP 2002550119 A JP2002550119 A JP 2002550119A JP 2002550119 A JP2002550119 A JP 2002550119A JP 2004537030 A5 JP2004537030 A5 JP 2004537030A5
- Authority
- JP
- Japan
- Prior art keywords
- region
- target mrna
- kit
- base
- target
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 108020004999 messenger RNA Proteins 0.000 claims 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims 3
- 230000000692 anti-sense effect Effects 0.000 claims 3
- 150000001875 compounds Chemical class 0.000 claims 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 2
- 210000001124 body fluid Anatomy 0.000 claims 2
- 239000010839 body fluid Substances 0.000 claims 2
- 230000000295 complement effect Effects 0.000 claims 2
- 230000003834 intracellular effect Effects 0.000 claims 2
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims 2
- 229910052698 phosphorus Inorganic materials 0.000 claims 2
- 239000011574 phosphorus Substances 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 108091027305 Heteroduplex Proteins 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 230000008685 targeting Effects 0.000 claims 1
- 210000002700 urine Anatomy 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/736,920 US20010024783A1 (en) | 1999-01-29 | 2000-12-13 | Non-invasive method for detecting target RNA |
| PCT/US2001/048694 WO2002048405A2 (en) | 2000-12-13 | 2001-12-13 | Non-invasive method for detecting target rna |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004537030A JP2004537030A (ja) | 2004-12-09 |
| JP2004537030A5 true JP2004537030A5 (enExample) | 2005-04-28 |
Family
ID=24961869
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002550119A Withdrawn JP2004537030A (ja) | 2000-12-13 | 2001-12-13 | 標的ｒｎａを検出するための非浸潤方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20010024783A1 (enExample) |
| EP (1) | EP1356110A2 (enExample) |
| JP (1) | JP2004537030A (enExample) |
| KR (1) | KR20030070584A (enExample) |
| AU (2) | AU3092202A (enExample) |
| CA (1) | CA2431646A1 (enExample) |
| WO (1) | WO2002048405A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050159381A1 (en) * | 2001-05-18 | 2005-07-21 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of chromosome translocation gene expression using short interfering nucleic acid (siNA) |
| US20030082594A1 (en) * | 2001-08-08 | 2003-05-01 | Gabe Christopher J. | System and method for analyzing resistance of a pathogen to one or more treatments |
| EP1451350A4 (en) * | 2001-11-05 | 2006-05-10 | Transgenomic Inc | PROCESSES, SYSTEMS AND KITS FOR THE ANALYSIS OF POLYNUCLEOTIDES |
| US20090093439A1 (en) * | 2002-02-20 | 2009-04-09 | Sirna Therapeutics, Inc. | RNA INTERFERENCE MEDIATED INHIBITION OF CHROMOSOME TRANSLOCATION GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| US8524676B2 (en) * | 2005-09-08 | 2013-09-03 | Sarepta Therapeutics, Inc. | Method for treating enterovirus or rhinovirus infection using antisense antiviral compounds |
| JP5850519B2 (ja) | 2011-05-09 | 2016-02-03 | ネッパジーン株式会社 | モルフォリノ搭載バブルリポソームを有効成分としてなる筋ジストロフィー治療薬 |
| EP2715367A2 (en) * | 2011-06-03 | 2014-04-09 | University of South Alabama | Methods and compositions for detecting endometrial or ovarian cancer |
| CN102559888A (zh) * | 2011-12-27 | 2012-07-11 | 芮屈生物技术（上海）有限公司 | 癌变前期CPE的mRNA水平原位杂交检测试剂盒及检测方法和应用 |
| WO2016179043A1 (en) * | 2015-05-01 | 2016-11-10 | Dermtech, Inc. | Non-invasive skin collection system |
| US20240318242A1 (en) * | 2022-01-28 | 2024-09-26 | City University Of Hong Kong | Methods and systems for measuring multiplex rna expression |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE312834T1 (de) * | 1989-12-20 | 2005-12-15 | Avi Biopharma Inc | Ungeladene, auf morpholin basierende polymere mit chiralen, phosphor enthaltenden brücken zwischen den untereinheiten |
| EP1173561A2 (en) * | 1999-01-29 | 2002-01-23 | Avi Biopharma, Inc. | Non-invasive method for detecting target rna |
-
2000
- 2000-12-13 US US09/736,920 patent/US20010024783A1/en not_active Abandoned
-
2001
- 2001-12-13 AU AU3092202A patent/AU3092202A/xx active Pending
- 2001-12-13 KR KR10-2003-7007904A patent/KR20030070584A/ko not_active Withdrawn
- 2001-12-13 WO PCT/US2001/048694 patent/WO2002048405A2/en not_active Ceased
- 2001-12-13 EP EP01991180A patent/EP1356110A2/en not_active Withdrawn
- 2001-12-13 AU AU2002230922A patent/AU2002230922B2/en not_active Ceased
- 2001-12-13 CA CA002431646A patent/CA2431646A1/en not_active Abandoned
- 2001-12-13 JP JP2002550119A patent/JP2004537030A/ja not_active Withdrawn
-
2003
- 2003-04-22 US US10/421,173 patent/US20030171328A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002535015A5 (enExample) | ||
| CN109843902B (zh) | 用于B型肝炎病毒感染的RNAi剂 | |
| EP0894129B1 (en) | Short external guide sequences | |
| AU2005302155B2 (en) | Antisense antiviral compounds and methods for treating filovirus infection | |
| KR102214740B1 (ko) | Mir-122를 조정하기 위한 마이크로rna 화합물 및 방법 | |
| US5985662A (en) | Antisense inhibition of hepatitis B virus replication | |
| US6583122B2 (en) | Nucleosides and oligonucleotides containing boron clusters | |
| JP2008526876A5 (enExample) | ||
| JP2004537030A5 (enExample) | ||
| JP2016502858A5 (enExample) | ||
| JP7515400B2 (ja) | Ｂ型肝炎ウイルス感染を治療するためのｆｕｂｐ１阻害剤の使用 | |
| JP2005500025A5 (enExample) | ||
| JP2005520489A5 (enExample) | ||
| JP2015504650A5 (enExample) | ||
| CN102762215A (zh) | Hbv反义抑制剂 | |
| JP2007504830A5 (enExample) | ||
| CN103620035A (zh) | 用于调节mir-21活性的微rna化合物以及方法 | |
| CN114846140A (zh) | 用于治疗hbv的靶向hbv的治疗性寡核苷酸和tlr7激动剂的药物组合 | |
| CN115698288A (zh) | 核酸、含有该核酸的药物组合物与siRNA缀合物及制备方法和用途 | |
| CA2166890A1 (en) | Enhancement of oligonucleotide inhibition of protein production, cell proliferation, and/or multiplication of infectious disease pathogens | |
| Alt et al. | Comparative inhibitory potential of differently modified antisense oligodeoxynucleotides on hepatitis C virus translation | |
| Vidalin et al. | In vitro inhibition of hepatitis C virus gene expression by chemically modified antisense oligodeoxynucleotides | |
| JP2004526737A5 (enExample) | ||
| WO2002048405A3 (en) | Non-invasive method for detecting target rna | |
| JP2004261017A5 (enExample) |